Interaction between antiretroviral boosters and corticosteroids can lead to development of Cushing's syndrome
Frequent drug-drug interactions in older people with HIV in France
Co-administration of dolutegravir-based treatment and short course of rifapentine/isoniazid (3HP) well tolerated in people living with HIV
Potential drug interactions among people with HIV taking statins
Italian study shows growth in heart and kidney problems in people living with HIV
Transgender women taking PrEP have lower levels of PrEP drugs, especially in rectal tissues, than cisgender men
The long tail of injectable PrEP is especially long for women
PrEP does not lower feminising hormone level in transgender women
